Cephalogics is developing a noninvasive portable imaging system to provide clinicians with valuable measures of cerebral perfusion status in brain-injured patients. Compact, convenient and easy to use, the Cephalogics system utilizes Diffuse Optical Tomography (DOT) technology to provide bedside imaging of multiple cerebral vascular regions. Undetected perfusion deficits lead to ischemia. Cephalogics detects perfusion deficits and enables early interventions to help avoid ischemia and associated adverse outcomes.
Cephalogics’ technology is the result of a partnership between Allied Minds and Dr. Joseph P. Culver at Washington University in St. Louis. Dr. Culver is a Professor in the Department of Radiology and a Diffuse Optical Tomography expert.
Cephalogics is a subsidiary of Allied Minds (LSE: ALM), an innovative U.S. science and technology development and commercialization company. More information about Allied Minds can be found at www.alliedminds.com
Company’s Keywords:
neuroimaging, medical device, cerebral oximetry, brain function monitoring
<0
<
<